What I liked: The science is potentially life altering. They are the only company currently pursuing this angle through the mitochondria. They have a tremendous IP portfolio. Their officers appear to be 1st class. They have gotten to the point of be ready to start human trials with only raising 18 million dollars. That is pretty much unheard of. They did issue an s-1 in September for a little over 6 million shares at about 2.70 a share. So the price may pull back some from yesterday. I am not shilling for the other sight but Dr. KSS is unparalleled in his willingness to share his knowledge and answer questions pertaining to biotech. I have an oversized (for me) investment in ARTH which is how I found out about SG and Dr. Kss. He thinks this may be the most exciting company He has found in years.
Recent CWBR News
- CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K) • Business Wire • 11/27/2023 11:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 10:21:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:01:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:05:22 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 01:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:42 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/06/2023 08:13:20 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:11:18 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/04/2023 01:14:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 01:12:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2023 04:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2023 08:47:59 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 09/12/2023 05:44:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:07:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:05:38 PM
- CohBar Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/14/2023 08:01:05 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 08/10/2023 09:30:56 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) • GlobeNewswire Inc. • 06/05/2023 12:05:22 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/30/2023 12:05:15 PM
- CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy • GlobeNewswire Inc. • 05/23/2023 11:30:39 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM